When the CAR is expressed on the T-cell surface (CAR T-cell), it mediates a non-MHC-restricted antigen recognition coupled to T-cell activation, a property scientists exploit to target tumor antigens and eradicate cancer. This evidence concerns the gene HLA-C and neoplasm.